| Ticker Details |
|
Erasca, Inc.
|
| IPO Date: |
July 16, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$5.66B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.28 | 4.16%
|
| Avg Daily Range (30 D): |
$0.49 | 2.72%
|
| Avg Daily Range (90 D): |
$0.59 | 4.00%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.5M |
| Avg Daily Volume (30 D): |
2.87M |
| Avg Daily Volume (90 D): |
4.64M |
| Trade Size |
| Avg Trade Size (Sh.): |
128 |
| Avg Trade Size (Sh.) (30 D): |
85 |
| Avg Trade Size (Sh.) (90 D): |
103 |
| Institutional Trades |
| Total Institutional Trades: |
1,532 |
| Avg Institutional Trade: |
$2.51M |
| Avg Institutional Trade (30 D): |
$3M |
| Avg Institutional Trade (90 D): |
$3.05M |
| Avg Institutional Trade Volume: |
.26M |
| Avg Institutional Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.79M |
| Avg Closing Trade (30 D): |
$8.99M |
| Avg Closing Trade (90 D): |
$10.04M |
| Avg Closing Volume: |
580.04K |
|
|
| News |
Aug 8, 2026 @ 10:34 PM
ROSEN, LEADING INVESTOR COUNSEL, Encourages Datava...
Source: Rosen Law Firm
|
Aug 8, 2026 @ 8:51 PM
ERASCA DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, ...
Source: Rosen Law Firm
|
Aug 7, 2026 @ 7:47 PM
ERASCA LEAD PLAINTIFF DEADLINE AUGUST 10th: Bragar...
Source: Bragar Eagel & Squire, P.C.
|
Aug 7, 2026 @ 7:44 PM
ERAS 3-DAY DEADLINE ALERT: Erasca, Inc. Investors ...
Source: Hagens Berman
|
Aug 7, 2026 @ 1:32 PM
Important Notice to Long-Term Shareholders of Eras...
Source: Grabar Law Office
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$-.95
|
$-.14
|
$-.6
|
|
Diluted EPS
|
$-.95
|
$-.14
|
$-.6
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-287.22M
|
$-44.08M
|
$-183.44M
|
|
Operating Income / Loss
|
$-302.68M
|
$-47.62M
|
$-187.91M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-23.6M
|
$-4.71M
|
$-26.55M
|
|
PE Ratio
|
|
|
|
|
|
|
